Allogeneic BMT for infantile acute leukemia: what is the optimal conditioning regimen?

Bone Marrow Transplant. 2002 Apr;29(7):630; author reply 631. doi: 10.1038/sj.bmt.1703420.
No abstract available

Publication types

  • Comment
  • Letter

MeSH terms

  • Acute Disease
  • Bone Marrow Transplantation* / adverse effects
  • Busulfan
  • Cyclophosphamide
  • Disease-Free Survival
  • Etoposide
  • Growth Disorders / chemically induced
  • Humans
  • Infant
  • Leukemia / mortality
  • Leukemia / therapy*
  • Radiation Injuries / etiology
  • Transplantation Conditioning* / adverse effects
  • Transplantation, Homologous* / adverse effects
  • Treatment Failure
  • Whole-Body Irradiation / adverse effects

Substances

  • Etoposide
  • Cyclophosphamide
  • Busulfan